» Articles » PMID: 34899707

Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea

Overview
Journal Front Immunol
Date 2021 Dec 13
PMID 34899707
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Rosacea is significantly associated with dementia, particularly Alzheimer's disease (AD). However, the common underlying molecular mechanism connecting these two diseases remains limited. This study aimed to reveal the common molecular regulatory networks and identify the potential therapeutic drugs for rosacea and AD. There were 747 overlapped DEGs (ol-DEGs) that were detected in AD and rosacea, enriched in inflammation-, metabolism-, and apoptosis-related pathways. Using the TF regulatory network analysis, 37 common TFs and target genes were identified as hub genes. They were used to predict the therapeutic drugs for rosacea and AD using the DGIdb/CMap database. Among the 113 predicted drugs, melatonin (MLT) was co-associated with both RORA and IFN-γ in AD and rosacea. Subsequently, network pharmacology analysis identified 19 pharmacological targets of MLT and demonstrated that MLT could help in treating AD/rosacea partly by modulating inflammatory and vascular signaling pathways. Finally, we verified the therapeutic role and mechanism of MLT on rosacea and . We found that MLT treatment significantly improved rosacea-like skin lesion by reducing keratinocyte-mediated inflammatory cytokine secretion and repressing the migration of HUVEC cells. In conclusion, this study contributes to common pathologies shared by rosacea and AD and identified MLT as an effective treatment strategy for rosacea and AD regulating inflammation and angiogenesis.

Citing Articles

Scutellarin Alleviates Neuronal Apoptosis in Ischemic Stroke via Activation of the PI3K/AKT Signaling Pathway.

Duan Z, Peng Y, Xu D, Yang Y, Wu Y, Wu C Int J Mol Sci. 2025; 26(5).

PMID: 40076795 PMC: 11901123. DOI: 10.3390/ijms26052175.


The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: The battle between PI3K and ROS.

Hu Q, Zhong X, Feng H, Li X, Zhang Z, Pan Y J Ginseng Res. 2025; 49(2):208-222.

PMID: 40061477 PMC: 11889380. DOI: 10.1016/j.jgr.2025.01.002.


Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and experiments.

Xin J, Song X, Zheng H, Li W, Qin Y, Wang W Front Vet Sci. 2025; 12:1524812.

PMID: 39917312 PMC: 11799295. DOI: 10.3389/fvets.2025.1524812.


Exploring melatonin's signalling pathways in the protection against age-related skin deterioration.

Taheri M, Seirafianpour F, Fallahian A, Hosseinzadeh A, Reiter R, Mehrzadi S Pharmacol Rep. 2025; .

PMID: 39883394 DOI: 10.1007/s43440-025-00699-5.


Network pharmacology: a crucial approach in traditional Chinese medicine research.

Zhai Y, Liu L, Zhang F, Chen X, Wang H, Zhou J Chin Med. 2025; 20(1):8.

PMID: 39800680 PMC: 11725223. DOI: 10.1186/s13020-024-01056-z.


References
1.
Salimi M, Barlow J, Saunders S, Xue L, Gutowska-Owsiak D, Wang X . A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013; 210(13):2939-50. PMC: 3865470. DOI: 10.1084/jem.20130351. View

2.
Sethi A, Kulkarni N, Sonar S, Lal G . Role of miRNAs in CD4 T cell plasticity during inflammation and tolerance. Front Genet. 2013; 4:8. PMC: 3560369. DOI: 10.3389/fgene.2013.00008. View

3.
Wang Q, Zhu D, Ping S, Li C, Pang K, Zhu S . Melatonin recovers sleep phase delayed by MK-801 through the melatonin MT receptor- Ca -CaMKII-CREB pathway in the ventrolateral preoptic nucleus. J Pineal Res. 2020; 69(3):e12674. DOI: 10.1111/jpi.12674. View

4.
Guo Q, Dong Y, Cao J, Wang Z, Zhang Z, Chen Y . Developmental changes of melatonin receptor expression in the spleen of the chicken, Gallus domesticus. Acta Histochem. 2015; 117(6):559-65. DOI: 10.1016/j.acthis.2015.05.002. View

5.
Majidinia M, Reiter R, Shakouri S, Yousefi B . The role of melatonin, a multitasking molecule, in retarding the processes of ageing. Ageing Res Rev. 2018; 47:198-213. DOI: 10.1016/j.arr.2018.07.010. View